Data / Drug companies / Altona Cosmetics Technology Sanayi Ve Ticaret Anonim Sirketi
Altona Cosmetics Technology Sanayi Ve Ticaret Anonim Sirketi: 25 products in the FDA NDC directory, labeler code 70474
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Altona Cosmetics Technology Sanayi Ve Ticaret Anonim Sirketi (labeler code 70474) lists 25 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 25 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 12, 2024.
The request: Watch Altona Cosmetics Technology Sanayi Ve Ticaret Anonim Sirketi (FDA labeler code 70474): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70474
- Products in commercial distribution
- 25
- Packages
- 25
- Finished drugs by generic name
- 1
- Prescription products
- 0
- Over the counter products
- 25
- Flagged as original packager
- 1 of 1 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 25
- Earliest marketing start
- January 29, 2023
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 25 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 25 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Octinoxate | 25 | 10 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 25 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Note BB 100 Porcelain | 70474-021 | Cream | Over the counter monograph drugs | September 12, 2024 |
| Note Mattifying Extreme Wear Foundation 130 Cool Rose | 70474-014 | Cream | Over the counter monograph drugs | September 12, 2024 |
| Note Mattifying Extreme Wear Foundation 116 Golden Beige | 70474-012 | Cream | Over the counter monograph drugs | September 12, 2024 |
| Note Mattifying Extreme Wear Foundation 114 Latte | 70474-010 | Cream | Over the counter monograph drugs | September 12, 2024 |
| Note Mattifying Extreme Wear Foundation 110 Smoke | 70474-008 | Cream | Over the counter monograph drugs | September 12, 2024 |
| Note BB 500 | 70474-024 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB 300 Light Beige | 70474-023 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB 200 Soft Ivory | 70474-022 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB Advanced Skin Corrector SPF 15, 02 | 70474-020 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB Advanced Skin Corrector SPF 15, 01 | 70474-019 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Sunglow Foundation | 70474-018 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB Concealer 03 | 70474-017 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB Concealer 02 | 70474-016 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note BB Concealer 01 | 70474-015 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 125 Ivory Beige | 70474-013 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 115 Ebony | 70474-011 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 113 Honey Bronze | 70474-009 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 108 Terra | 70474-007 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation, 100 Cashmere Beige | 70474-006 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 08 Sunny | 70474-005 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 07 Apricot | 70474-004 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 04 Sand | 70474-003 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 03 Medium Beige | 70474-002 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation 02 Natural Beige | 70474-001 | Cream | Over the counter monograph drugs | January 29, 2023 |
| Note Mattifying Extreme Wear Foundation | 70474-000 | Cream | Over the counter monograph drugs | January 29, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.